RNA NanoTherapeutics reposted this
𝐓𝐡𝐞 𝐧𝐚𝐧𝐨𝐩𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐟𝐨𝐫𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐡𝐚𝐬 𝐰𝐢𝐭𝐧𝐞𝐬𝐬𝐞𝐝 𝐚 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫𝐚𝐛𝐥𝐞 𝐫𝐢𝐬𝐞 𝐢𝐧 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲, 𝐰𝐢𝐭𝐡 𝐚𝐧 𝐚𝐧𝐧𝐮𝐚𝐥𝐢𝐳𝐞𝐝 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 𝐨𝐟 ~𝟏𝟓% 𝐛𝐞𝐭𝐰𝐞𝐞𝐧 𝟐𝟎𝟏𝟖 𝐚𝐧𝐝 𝟐𝟎𝟐𝟐 Given the immense potential of nanoparticles in efficient drug delivery and biomedical imaging, their demand has increased significantly. However, formulation of nanoparticles is a challenging process, which requires technical expertise, substantial financial investment, and stringent regulatory approval. As a result, outsourcing has gained popularity, enabling drug developers and researchers to access a wider array of advanced nanoparticle formulation technologies and cost-effective services. Currently, over 80 companies offer a diverse range of nanoparticle formulation services at various operational scales. This landscape encompasses both well-established and emerging players equipped with the necessary expertise to develop and manufacture nanoparticle-based drugs for a vast range of application areas. Click here to read more https://lnkd.in/dBdA7qNV Some of the players listed in our report include Optimeos Life Sciences Cello Therapeutics, Inc. Novavax Ixaka Advanced NanoTherapies, Inc leon-nanodrugs Sun Pharma Advanced Research Company Ltd. Nanovex Biotechnologies VSPARTICLE Speratum Biopharma, Inc. Chimeron Bio NanoViricides, Inc. Genprex, Inc. Toralgen RNA NanoTherapeutics TLC BioSciences ClostraBio, Inc Learn more about Roots Analysis consulting services: https://lnkd.in/dyfAawqZ #nanoparticleformulation #nanoparticleformulations #nanoparticledevelopmentmarket #nanoparticle #marketresearch #marketinsights #RootsAnalysis